INTELLIGENCE IN ACTION

Tapping Into Technology and Data to Respond to COVID-19

October 09, 2020

When Dr. Amy Abernethy, the Principal Deputy Commissioner & Acting CIO of the United States Food and Drug Administration (FDA), started at the agency last year, she saw an urgent need to modernize FDA's technology and data approaches and capabilities.

The arrival of COVID-19 only further underscored this necessity.

Surescripts CEO Tom Skelton recently sat down with Dr. Abernethy for a fireside chat about the successes and challenges of this year, the imperative data needs of public health agencies like the FDA and the value of public-private partnerships.


“What happened in March is that we realized that we needed to figure out better ways to develop relationships and access data sets that were already being formed—perhaps pre-COVID—but now could inform our COVID activities,” Dr. Abernethy shared.

To solve this problem, the FDA created and publicly shared a prioritized list of questions that the agency wanted to understand. This information resulted in collaborative efforts across industries as data holders, analytic teams, and other people worked together to solve COVID-19 related issues.

Surescripts was one of many organizations eager to help. “One question Surescripts was interested in trying to understand was the patterns of outpatient prescribing within the context of people with COVID-19. [This is] something that [the FDA] really needed to understand – what’s going on out there?”

When asked about the other types of innovations she expects the FDA to stay focused on post-COVID-19, Dr. Abernethy shared, “One of the big areas that I see as persisting is the familiarity of how we can use data to answer many different questions across the agency, as opposed to this classic thinking of data as something that either is acquired in a clinical trial or acquired in something that’s intended to be a substitute for a clinical trial.”

Dr. Abernethy concluded, “I think we have this opportunity now at the agency to learn through COVID.” Here at Surescripts, we can agree that we all have an opportunity to learn from this moment.

Discover how the COVID-19 pandemic has accelerated the digital transformation of healthcare—and how Surescripts is responding to the challenge.

Related Articles

October 05, 2020

A Faxless Future: Dare We Dream?

We’re well into the digital age, but the fax machine is ever present in healthcare, accounting for 75% of all medical communication, and creating headaches for doctor’s offices, pharmacies and hospitals across the nation. Read more...
September 30, 2020

The Toothpaste Is Not Going Back Into the Tube: Telehealth Is Here to Stay

As Zipnosis Founder and CEO Jon Pearce recently put it, “This toothpaste is not going back into the tube. Telehealth will be the new normal after the coronavirus pandemic subsides.” Read more...
September 24, 2020

5 Questions: Tiffany Rosenquist on Bringing the Head and the Heart Together for a Better Customer Experience

Tiffany Rosenquist’s love of people is what makes her such a passionate and joyful customer experience professional. Her ability to bring together the analytical and the emotional side of healthcare enables deep listening, empathetic responsiveness and clear communication—all especially necessary elements to helping our customers succeed during COVID-19 and beyond. 

Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX